16151523

Harden CL

2005

Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease.

16152826

Yang YS

2005

[Clinical study of ganshao capsule in treating clomiphene-resistant polycystic ovarian syndrome].

16154042

Zhu WJ

2005

Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.

16155076

Cataldo NA

2006

Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.

16155079

Dursun P

2006

Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?

16159937

Ho CK

2005

Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells.

16161310

Bruzeau J

2005

[Metabolic syndrome and polycystic ovary syndrome].

16167950

Kandil M

2005

Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome.

16169420

Palomba S

2005

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome.

16169421

Goodarzi MO

2005

Polycystic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance.

16169424

Hassa H

2005

The hirsutism scoring system should be population specific.

16169430

Onalan G

2005

Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial.

16171731

Fernandes AR

2005

Insulin resistance in adolescents with menstrual irregularities.

16174719

Zhou R

2005

Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.

16183189

Vrtacnik-Bokal E

2006

Uterine arterial blood flow and the substances of ovarian renin-angiotensin system in women with polycystic ovaries undergoing in vitro fertilization.

16185097

Stadtmauer L

2005

Management of infertility in women with polycystic ovary syndrome : a practical guide.

16189063

Levri KM

2005

Metformin as treatment for overweight and obese adults: a systematic review.

16189250

Escobar-Morreale HF

2005

The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery.

16189386

Cho LW

2005

The biological variation of C-reactive protein in polycystic ovarian syndrome.

16191492

Brown AJ

2005

Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings.

16192401

Minge CE

2006

Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages.

16195501

Manni L

2006

Effect of anti-NGF on ovarian expression of alpha1- and beta2-adrenoceptors, TrkA, p75NTR, and tyrosine hydroxylase in rats with steroid-induced polycystic ovaries.

16195901

Ballian N

2006

Pregnancy following ovarian drilling in a woman with polycystic ovary syndrome and nine previous first trimester miscarriages.

16198620

Agarwal N

2005

Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH).

16199428

Lemay A

2006

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.

16199429

Tang T

2006

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study.

16200842

Allen HF

2005

Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.

16202290

Zhao JL

2005

[Correlation between 4G and 5G genetypes distribution of plasminogen activator inhibitor-1 gene polymorphism in its promoter region with polycystic ovarian syndrome].

16208308

Pallotti S

2005

[Relationship between insulin secretion, and thyroid and ovary function in patients suffering from polycystic ovary].

16210005

Pak SC

2005

Role of Korean red ginseng total saponins in rat infertility induced by polycystic ovaries.

16210015

Singh KB

2005

Persistent estrus rat models of polycystic ovary disease: an update.

16210021

Tamura N

2005

Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome.

16212648

Haller K

2005

IgG, IgA and IgM antibodies against FSH: serological markers of pathogenic autoimmunity or of normal immunoregulation?

16213846

Esinler I

2005

Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.

16213847

Siow Y

2005

Serum M?llerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome.

16213854

Yoo RY

2005

Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study.

16215603

Carlsen SM

2005

[Polycystic ovarian syndrome and diabetes].

16217983

Bhatia V

2005

Insulin resistance in polycystic ovarian disease.

16219521

Glueck CJ

2005

Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy.

16219714

Vink JM

2006

Heritability of polycystic ovary syndrome in a Dutch twin-family study.

16219719

Tasali E

2006

Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome.

16219952

Lam PM

2005

Polycystic ovarian syndrome in Hong Kong Chinese women: patient characteristics and diagnostic criteria.

16222950

Fleischman A

2005

Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance.

16224516

Sun CL

2005

[Expression of novel apoptosis-related protein PDCD5 in granulosa cells of polysystic ovary syndrome].

16225963

Rasgon NL

2005

Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis.

16228060

Owj M

2005

The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.

16238102

Recabarreni SE

2005

Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero.

16243001

Morris GL 3rd

2005

Human sexuality, sex hormones, and epilepsy.

16248240

Chen LS

2005

[Clinical research on combined therapy of diane-35 with modified yougui pill on polycystic ovarian syndrome].

16249279

Gonz?lez F

2006

Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.

16249280

Coviello AD

2006

Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.

16249284

Ehrmann DA

2006

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.

16253975

Palomba S

2006

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.

16254911

Battaglia C

2005

Female precocious puberty, obesity and polycystic-like ovaries.

16259217

Allolio B

2005

Understanding polycystic ovarian syndrome.

16259222

Baillargeon JP

2005

Use of insulin sensitizers in polycystic ovarian syndrome.

16259573

Teede HJ

2005

Insulin-sensitisers in the treatment of polycystic ovary syndrome.

16259799

Chadwick CA

2005

Development of a method for the measurement of dehydroepiandrosterone sulphate by liquid chromatography-tandem mass spectrometry.

16262133

Morin-Papunen L

2005

[How obesity of girls during childhood and adolescent reflects to reproductive ability].

16263811

Qin K

2006

Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome.

16263814

Baillargeon JP

2006

Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

16263820

Carmina E

2006

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.

16275246

Guido M

2005

Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome.

16275260

Zulian E

2005

The M235T polymorphism of the angiotensinogen gene in women with polycystic ovary syndrome.

16280032

Manni L

2005

Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries.

16285579

Skommer J

2005

Gherlin expression in women with polycystic ovary syndrome--a preliminary study.

16289780

Mouraux T

2005

[Weight of obesity in (pre)type 2 diabetes in children and adolescents: how and when to screen for?].

16290888

Foecking EM

2005

Effects of experimental hyperandrogenemia on the female rat reproductive axis: suppression of progesterone-receptor messenger RNA expression in the brain and blockade of luteinizing hormone surges.

16293774

Akhtar MK

2005

Cytochrome b(5) modulation of 17{alpha} hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis.

16295039

Zouboulis CC

2003

[Treatment of acne with antiandrogens--an evidence-based review].

16295159

Snyder BS

2005

Polycystic ovary syndrome (PCOS) in the adolescent patient: recommendations for practice.

16300709

Hasan JA

2005

Impact of metformin therapy in patients with polycystic ovarian syndrome.

16305707

Trolle B

2005

Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome.

16306871

Pellicano M

2005

[Voluminous ectopic polycystic ovaries in Mayer-Rokitansky-K?ster-Hauser syndrome].

16308143

Sir-Petermann T

2005

Polycystic ovary syndrome, a pathway to type 2 diabetes.

16309038

Ortiz N??ez DA

2005

[Insulin sensitizers in the treatment of polycystic ovary].

16310646

Patel SM

2006

Fertility in polycystic ovary syndrome.

16311212

Arner P

2005

Human fat cell lipolysis: biochemistry, regulation and clinical role.

16311293

Lakhani K

2006

Aortic function is compromised in a rat model of polycystic ovary syndrome.

16313910

Cussons AJ

2006

Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.

16316811

Onalan G

2005

Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

16316841

Yilmaz M

2005

Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.

16316846

Bar-Hava I

2005

Controlled ovarian hyperstimulation: does prolonged stimulation justify cancellation of in vitro fertilization cycles?

16319656

Schneider DJ

2005

Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance.

16320555

Thomson JC

2005

Chronic pelvic pain associated with autoimmunity and systemic and peritoneal inflammation and treatment with immune modification.

16322388

Lystedt E

2005

Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness.

16322391

Hahn S

2005

Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.

16324242

Yang HX

2005

[A prospective study of risk factors in pregnant women with abnormal glucose metabolism].

16329683

Rabelo Acevedo M

2005

Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.

16330807

Florez JC

2005

Genetic susceptibility for polycystic ovary syndrome on chromosome 19: advances in the genetic dissection of complex reproductive traits.

16331111

Kaaja RJ

2006

Insulin resistance and sympathetic overactivity in women.

16331562

Zhao JL

2005

[Study on the (TAAAA)n repeat polymorphism in sex hormone-binding globulin gene and the SHBG serum levels in putative association with the glucose metabolic status of Chinese patients suffering from polycystic ovarian syndrome in Shandong province].

16335907

Yilmaz M

2005

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.

16335908

Charnvises K

2005

Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.

16335909

Heinonen S

2005

Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome.

16337616

Luque-Ram?rez M

2006

Genomic variants in polycystic ovary syndrome.

16337726

Yucel A

2006

The association of serum androgens and insulin resistance with fat distribution in polycystic ovary syndrome.

16337728

Kurabayashi T

2006

Prognostic factors for ovulatory response with clomiphene citrate in polycystic ovary syndrome.

16338908

Lewandowski KC

2006

Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome.

16343096

Palomba S

2005

Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome.